Mimedx (MDXG) FCF Margin Growth (5y) (2016 - 2026)
Powered by 
Analysis
Mimedx (MDXG) FCF Margin Growth (5y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn |
| 10 | Mimedx | 683.56 Mn | 547.72 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,824.00 |
| Mar 31, 2026 | 1,659.00 |
| Dec 31, 2025 | 3,901.00 |
| Sep 30, 2025 | 3,382.00 |
| Jun 30, 2025 | 2,098.00 |
| Mar 31, 2025 | 2,711.00 |
| Dec 31, 2024 | 5,111.00 |
| Sep 30, 2024 | 2,688.00 |
| Jun 30, 2024 | 2,225.00 |
| Mar 31, 2024 | 3,056.00 |
| Dec 31, 2023 | 1,050.00 |
| Sep 30, 2023 | 1,371.00 |
| Jun 30, 2023 | 99.00 |
| Mar 31, 2023 | -1,498.00 |
| Dec 31, 2022 | -3,092.00 |
| Sep 30, 2022 | -1,892.00 |
| Jun 30, 2022 | -1,961.00 |
| Mar 31, 2022 | -3,168.00 |
| Dec 31, 2021 | -4,228.00 |
| Sep 30, 2021 | 715.00 |